Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.08.2023 | Case report

Pembrolizumab

Acute kidney injury: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Pirovano M, et al. ACUTE KIDNEY INJURY (AKI) IN CANCER PATIENTS TREATED WITH COMBO THERAPIES: CHEMOTHERAPY, OR IMMUNOTHERAPY, THAT IS THE QUESTION. Nephrology Dialysis Transplantation 38 (Suppl. 1): i1120-i1121 abstr. #3652, Jun 2023. Available from: URL: http://doi.org/10.1093/ndt/gfad063c_3652 [abstract] Pirovano M, et al. ACUTE KIDNEY INJURY (AKI) IN CANCER PATIENTS TREATED WITH COMBO THERAPIES: CHEMOTHERAPY, OR IMMUNOTHERAPY, THAT IS THE QUESTION. Nephrology Dialysis Transplantation 38 (Suppl. 1): i1120-i1121 abstr. #3652, Jun 2023. Available from: URL: http://​doi.​org/​10.​1093/​ndt/​gfad063c_​3652 [abstract]
Metadaten
Titel
Pembrolizumab
Acute kidney injury: case report
Publikationsdatum
01.08.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-45341-x

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Antituberculars

Case report

Testosterone